Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

COVID shook the world. Since then, a billion people worldwide have come down with the virus. New research reveals this ...

Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...

President trump- reinstating thousands of military members who were dismissed for refusing the covid-19 vaccine in 2021.He ...

The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to ...

Here’s what to know about the Trump administration’s order and which information is still available to California residents.

Invivyd (IVVD) announced the submission to the U.S. Food and Drug Administration, FDA, of an updated immunobridging analysis of pemivibart as ...

The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...

Citing unverified data, Robert F. Kennedy Jr. claimed in December 2021 that the Covid-19 vaccine was the “deadliest vaccine ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

Republicans, on the other hand, were twice as likely to trust Trump (84%), Kennedy (81%), and Mehmet Oz (83%) — who is Trump’s nominee to lead the Center for Medicaid and Medicare Services. Less than ...